<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8903467" created="25/08/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8903467</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><cons id="T1" lex="(AND Nasal_NK-cell_lymphoma T-cell_lymphoma)" sem="(AND Cell_natural Cell_natural)"><frag id="F1">Nasal NK-</frag> and <frag id="F2">T-cell</frag> <frag id="F3">lymphomas</frag></cons> share the same type of <term id="T2" lex="Epstein-Barr_virus_latency" sem="Other"><term id="T3" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> latency</term> as <term id="T4" lex="nasopharyngeal_carcinoma" sem="Tissue_natural">nasopharyngeal carcinoma</term> and <term id="T5" lex="Hodgkin&apos;s_disease" sem="Other">Hodgkin&apos;s disease</term>.</sentence>
<event id="E101">
<type class="Viral_life_cycle"/>
<theme idref="T3"/>
<clue><clueLoc>Nasal NK-</clueLoc> and T-<clueLoc>cell lymphomas</clueLoc> share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and Hodgkin&apos;s disease.</clue>
</event>
<event id="E201">
<type class="Viral_life_cycle"/>
<theme idref="T3"/>
<clue>Nasal NK- and <clueLoc>T-cell lymphomas</clueLoc> share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and Hodgkin&apos;s disease.</clue>
</event>
<event id="E102">
<type class="Viral_life_cycle"/>
<theme idref="T3"/>
<clue>Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus <clueType>latency</clueType> as <clueLoc>nasopharyngeal carcinoma</clueLoc> and Hodgkin&apos;s disease.</clue>
</event>
<event id="E202">
<type class="Viral_life_cycle"/>
<theme idref="T3"/>
<clue>Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus <clueType>latency</clueType> as nasopharyngeal carcinoma and <clueLoc>Hodgkin&apos;s disease</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="nasal_T/NK-cell_lymphoma" sem="Cell_natural">Nasal T/NK-cell lymphomas</term> can be further separated into those of <term id="T7" lex="natural_killer_(NK)_cell_lineage" sem="Cell_natural">natural killer (NK) cell lineage</term> or of <term id="T8" lex="T-cell_lineage" sem="Cell_natural">T-cell lineage</term>, with differences in cellular phenotype, <term id="T9" lex="T-cell_receptor_(TcR)_gene_rearrangement" sem="Other"><term id="T10" lex="T-cell_receptor_(TcR)_gene" sem="DNA_domain_or_region"><term id="T11" lex="T-cell_receptor" sem="Protein_family_or_group">T-cell receptor</term> (TcR) gene</term> rearrangement</term> and <term id="A1" sem="RNA_molecule">TcR transcript</term> expression.</sentence>
<event KT="Other" id="E1">
<type class="DNA_recombination"/>
<theme idref="T10"/>
<clue>Nasal T/NK-cell lymphomas can be further separated into those of <clueLoc>natural killer (NK) cell lineage</clueLoc> or of <clueLoc>T-cell lineage</clueLoc>, with differences in cellular phenotype, T-cell receptor (TcR) gene <clueType>rearrangement</clueType> and TcR transcript expression.</clue>
</event>
<event KT="Other" id="E2">
<type class="Transcription"/>
<theme idref="A1"/>
<clue>Nasal T/NK-cell lymphomas can be further separated into those of <clueLoc>natural killer (NK) cell lineage</clueLoc> or of <clueLoc>T-cell lineage</clueLoc>, with differences in cellular phenotype, T-cell receptor (TcR) gene rearrangement and TcR transcript <clueType>expression</clueType>.</clue>
</event>
<sentence id="S3">Both <cons id="T12" lex="(AND NK-cell_subtype T-cell_subtype)" sem="(AND Cell_natural Cell_natural)"><frag id="F4">NK-</frag> and <frag id="F5">T-cell</frag> <frag id="F6">subtypes</frag></cons> are closely associated with <term id="T13" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> (<term id="T14" lex="EBV" sem="Virus">EBV</term>).</sentence>
<sentence id="S4">In this study, <term id="T15" lex="EBV_gene_expression" sem="Other"><term id="T16" lex="EBV_gene" sem="DNA_family_or_group"><term id="T17" lex="EBV" sem="Virus">EBV</term> gene</term> expression</term> was determined in 23 cases of <term id="T18" lex="nasal_lymphoma" sem="Tissue_natural">nasal lymphoma</term> (<term id="T19" lex="NL" sem="Tissue_natural">NL</term>) by <term id="T20" lex="in_situ_hybridisation" sem="Other">in situ hybridisation</term> (<term id="T21" lex="ISH" sem="Other">ISH</term>), <term id="T22" lex="reverse_transcriptase-polymerase_chain_reaction" sem="Other"><term id="T23" lex="reverse_transcriptase" sem="Protein_molecule">reverse transcriptase</term>-polymerase chain reaction</term> (<term id="T24" lex="RT-PCR" sem="Other">RT-PCR</term>) and <term id="T25" lex="immunohistochemistry" sem="Other">immunohistochemistry</term> (<term id="T26" lex="IH" sem="Other">IH</term>).</sentence>
<event KT="Analysis" id="E3" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T16"/>
<clue>In this study, EBV gene <clueType>expression</clueType> was <clueKT>determined</clueKT> <clueLoc>in 23 cases of nasal lymphoma (NL)</clueLoc> <clueExperiment>by in situ hybridisation (ISH)</clueExperiment>, <clueExperiment>reverse transcriptase-polymerase chain reaction (RT-PCR)</clueExperiment> and <clueExperiment>immunohistochemistry (IH)</clueExperiment>.</clue>
</event>
<sentence id="S5">Of the 23 cases, 19 were classified as <term id="T27" lex="NK-cell_tumor" sem="Tissue_natural">NK-cell</term> and 4 as <term id="T28" lex="T-cell_tumour" sem="Tissue_natural">T-cell tumours</term>.</sentence>
<sentence id="S6"><term id="T29" lex="ISH" sem="Other">ISH</term> for <term id="T30" lex="EBV-encoded_small_non-polyadenylated_RNA" sem="RNA_family_or_group"><term id="T31" lex="EBV" sem="Virus">EBV</term>-encoded small non-polyadenylated RNAs</term> showed that all cases, whether NK or T, harboured <term id="T32" lex="EBV" sem="Virus">EBV</term> in virtually all <term id="T33" lex="tumour_cell" sem="Cell_natural">tumour cells</term>.</sentence>
<sentence id="S7"><term id="T34" lex="RT-PCR" sem="Other">RT-PCR</term> demonstrated that <term id="T35" lex="NL" sem="Cell_natural">NL</term> of both subtypes expressed <term id="T36" lex="EBNAI" sem="Protein_molecule">EBNAI</term> of the <term id="T37" lex="QUK_splice_pattern" sem="Other">QUK splice pattern</term>, the <term id="T38" lex="latent_membrane_protein" sem="Protein_family_or_group">latent membrane proteins</term>, <cons id="T39" lex="(AND LMP1 LMP2)" sem="(AND Protein_molecule Protein_molecule)"><frag id="F7"><term id="A2" sem="Protein_molecule">LMP</term></frag><frag id="F8"><term id="A3" sem="Protein_molecule">1</term></frag> and <frag id="F9"><term id="A4" sem="Protein_molecule">2</term></frag></cons> and the <term id="T40" lex="BamHI_A_rightward_transcript" sem="RNA_family_or_group">BamHI A rightward transcripts</term> in the absence of <term id="T41" lex="EBNA2_mRNA" sem="RNA_family_or_group">EBNA2 mRNAs</term>, compatible with the <term id="T42" lex="latency_type_II_pattern" sem="Other">latency type II pattern</term>.</sentence>
<event KT="Analysis" id="E4">
<type class="Gene_expression"/>
<theme idref="T36"/>
<clue><clueExperiment>RT-PCR</clueExperiment> <clueKT>demonstrated</clueKT> that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event KT="Analysis" id="E5">
<type class="Gene_expression"/>
<theme idref="A2" idref1="A3"/>
<clue><clueExperiment>RT-PCR</clueExperiment> <clueKT>demonstrated</clueKT> that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event KT="Analysis" id="E6">
<type class="Gene_expression"/>
<theme idref="A2" idref1="A4"/>
<clue><clueExperiment>RT-PCR</clueExperiment> <clueKT>demonstrated</clueKT> that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event KT="Analysis" id="E7">
<type class="Transcription"/>
<theme idref="T40"/>
<clue><clueExperiment>RT-PCR</clueExperiment> <clueKT>demonstrated</clueKT> that <clueLoc>NL of both subtypes</clueLoc> <clueType>expressed</clueType> EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the absence of EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E8">
<type class="Transcription"/>
<theme idref="T41"/>
<clue><clueExperiment>RT-PCR</clueExperiment> demonstrated that <clueLoc>NL of both subtypes</clueLoc> expressed EBNAI of the QUK splice pattern, the latent membrane proteins, LMP1 and 2 and the BamHI A rightward transcripts in the <clueType><cluePolarity>absence</cluePolarity></clueType> <linkTheme>of</linkTheme> EBNA2 mRNAs, compatible with the latency type II pattern.</clue>
</event>
<sentence id="S8">In addition, analysis of <term id="T43" lex="EBV_protein_expression" sem="Other"><term id="A5" sem="Protein_family_or_group"><term id="T44" lex="EBV" sem="Virus">EBV</term> protein</term> expression</term> by <term id="T45" lex="IH" sem="Other">IH</term> revealed a heterogeneous pattern of <term id="T46" lex="EBV_gene_expression" sem="Other"><term id="T47" lex="EBV_gene" sem="DNA_family_or_group"><term id="T48" lex="EBV" sem="Virus">EBV</term> gene</term> expression</term> at the single-cell level consisting of both <cons id="T49" lex="(AND LMP1+_tumour_cell LMP1-_tumour_cell)" sem="(AND Cell_natural Cell_natural)"><frag id="F10">LMP1+</frag> and <frag id="F11">LMP1-</frag> <frag id="F12">tumour cells</frag></cons>, suggesting a mixture of <cons id="C1" lex="(AND latency_I latency_II)" sem="(AND Other Other)"><frag id="F13">latency</frag> <frag id="F14">I</frag> and <frag id="F15">II</frag></cons>.</sentence>
<event KT="Investigation" id="E9" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>In addition, <clueKT>analysis</clueKT> of EBV protein <clueType>expression</clueType> by IH revealed a heterogeneous pattern of EBV gene expression at the single-cell level consisting of both LMP1+ and LMP1- tumour cells, suggesting a mixture of latency I and II.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>In addition, analysis of EBV protein expression <clueExperiment>by IH</clueExperiment> <clueKT>revealed</clueKT> a heterogeneous pattern of EBV gene <clueType>expression</clueType> at the single-cell level consisting of both <clueLoc>LMP1+</clueLoc> and LMP1- <clueLoc>tumour cells</clueLoc>, suggesting a mixture of latency I and II.</clue>
</event>
<event KT="Analysis" id="E110">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>In addition, analysis of EBV protein expression <clueExperiment>by IH</clueExperiment> <clueKT>revealed</clueKT> a heterogeneous pattern of EBV gene <clueType>expression</clueType> at the single-cell level consisting of both LMP1+ and <clueLoc>LMP1- tumour cells</clueLoc>, suggesting a mixture of latency I and II.</clue>
</event>
<sentence id="S9">Although 2 <term id="T51" lex="early_lytic_transcript" sem="Protein_family_or_group">early lytic transcripts</term>, <term id="T52" lex="BZLF1" sem="Protein_molecule">BZLF1</term> and <term id="T53" lex="BHRF1" sem="Protein_molecule">BHRF1</term>, were also detected in 13 and 10 cases, respectively, the lack of <term id="T54" lex="ZEBRA_staining" sem="Other"><term id="T55" lex="ZEBRA" sem="Protein_molecule">ZEBRA</term> staining</term> in any case indicates that these lytic transcripts are most likely expressed by rare <term id="A6" sem="Cell_natural">cells</term> in the biopsies entering lytic cycle.</sentence>
<event id="E11">
<type class="Gene_expression"/>
<theme idref="T52"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also <clueType><clueKT>detected</clueKT></clueType> <clueLoc>in 13</clueLoc> and 10 <clueLoc>cases</clueLoc>, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event id="E12">
<type class="Gene_expression"/>
<theme idref="T53"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also <clueType><clueKT>detected</clueKT></clueType> <clueLoc>in</clueLoc> 13 and <clueLoc>10 cases</clueLoc>, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E13">
<type class="Gene_expression"/>
<theme idref="T55"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the <clueType><cluePolarity>lack</cluePolarity></clueType> <linkTheme>of</linkTheme> ZEBRA staining <clueLoc>in any case</clueLoc> indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies entering lytic cycle.</clue>
</event>
<event KT="Other" id="E14">
<type class="Viral_life_cycle"/>
<theme idref="A6"/>
<cause idref="T44"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case indicates that these lytic transcripts are most likely expressed by rare cells in the biopsies <clueType>entering lytic cycle</clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event CL="L2" KT="Analysis" id="E15">
<type class="Gene_expression"/>
<theme idref="T52"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case <clueKT>indicates</clueKT> that <corefTheme>these lytic transcripts</corefTheme> are <clueCL>most likely</clueCL> <clueType>expressed</clueType> <clueLoc>by rare cells in the biopsies entering lytic cycle</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E16">
<type class="Gene_expression"/>
<theme idref="T53"/>
<clue>Although 2 early lytic transcripts, BZLF1 and BHRF1, were also detected in 13 and 10 cases, respectively, the lack of ZEBRA staining in any case <clueKT>indicates</clueKT> that <corefTheme>these lytic transcripts</corefTheme> are <clueCL>most likely</clueCL> <clueType>expressed</clueType> <clueLoc>by rare cells in the biopsies entering lytic cycle</clueLoc>.</clue>
</event>
<sentence id="S10">The <term id="T56" lex="viral_transcriptional_pattern" sem="Other">viral transcriptional pattern</term> similar to that of <term id="T57" lex="nasopharyngeal_carcinoma" sem="Tissue_natural">nasopharyngeal carcinoma</term> and <term id="T58" lex="Hodgkin&apos;s_disease" sem="Other">Hodgkin&apos;s disease</term> suggests that <term id="T59" lex="EBV" sem="Virus">EBV</term> can exploit <term id="A101" sem="Other"><term id="T60" lex="common_regulatory_mechanism" sem="Other">common regulatory mechanisms</term> for <term id="T61" lex="gene_transcription" sem="Other"><term id="A21" sem="DNA_domain_or_region">gene</term> transcription</term></term> in diverse host cell types.</sentence>
<event id="E17">
<type class="Transcription"/>
<theme idref="T59"/>
<clue><corefTheme>The viral</corefTheme> <clueType>transcriptional pattern</clueType> similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common regulatory mechanisms for gene transcription in diverse host cell types.</clue>
</event>
<event KT="Other" id="E18">
<type class="Transcription"/>
<theme idref="A21"/>
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common regulatory mechanisms for gene <clueType>transcription</clueType> in diverse host cell types.</clue>
</event>
<event KT="Other" id="E19">
<type class="Regulation"/>
<theme idref="E18"/>
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease suggests that EBV can exploit common <clueType>regulatory mechanisms</clueType> <linkTheme>for</linkTheme> gene transcription <clueLoc>in diverse host cell types</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Regulation"/>
<theme idref="T59"/>
<cause idref="A101"/>
<clue>The viral transcriptional pattern similar to that of nasopharyngeal carcinoma and Hodgkin&apos;s disease <clueKT>suggests</clueKT> that EBV <clueCL>can</clueCL> <clueType>exploit</clueType> common regulatory mechanisms for gene transcription <clueLoc>in diverse host cell types</clueLoc>.</clue>
<comment>TPS A101</comment></event>
<sentence id="S11">Down-regulation of <term id="T62" lex="immunogenic_protein" sem="Protein_family_or_group">immunogenic proteins</term> (<term id="T63" lex="EBNA2-EBNA6" sem="Protein_family_or_group"><term id="A22" sem="Protein_molecule">EBNA2</term>-<term id="A23" sem="Protein_molecule">EBNA6</term></term>) in <term id="A25" sem="Tissue_natural">nasal lymphoma</term> may enable <term id="T64" lex="tumour_cell" sem="Cell_natural">tumour cells</term> to evade host <term id="T65" lex="cytotoxic_T-cell_surveillance" sem="Other"><term id="A24" sem="Cell_natural">cytotoxic T-cell</term> surveillance</term>.</sentence>
<event KT="Other" id="E21">
<type class="Negative_regulation"/>
<theme idref="A22"/>
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> immunogenic proteins (EBNA2-EBNA6) <clueLoc>in nasal lymphoma</clueLoc> may enable tumour cells to evade host cytotoxic T-cell surveillance.</clue>
<comment>CAUTION: EBNA2-EBNA6 includes EBNA3, EBNA4 and EBNA5</comment></event>
<event KT="Other" id="E22">
<type class="Negative_regulation"/>
<theme idref="A23"/>
<clue><clueType>Down-regulation</clueType> <linkTheme>of</linkTheme> immunogenic proteins (EBNA2-EBNA6) <clueLoc>in nasal lymphoma</clueLoc> may enable tumour cells to evade host cytotoxic T-cell surveillance.</clue>
</event>
<event KT="Other" id="E23">
<type class="Cell_recognition"/>
<theme idref="T64"/>
<theme idref="A24"/>
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma may enable tumour cells to evade host cytotoxic T-cell <clueType>surveillance</clueType>.</clue>
</event>
<event CL="L1" KT="Analysis" id="E24">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E21"/>
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma <clueCL>may</clueCL> <clueType><clueKT>enable</clueKT></clueType> tumour cells <clueType>to evade</clueType> host cytotoxic T-cell surveillance.</clue>
</event>
<event CL="L1" KT="Analysis" id="E25">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="E22"/>
<clue>Down-regulation of immunogenic proteins (EBNA2-EBNA6) in nasal lymphoma <clueCL>may</clueCL> <clueType><clueKT>enable</clueKT></clueType> tumour cells <clueType>to evade</clueType> host cytotoxic T-cell surveillance.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
